4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-22-001522
Chief Medical Officer acquired 28,333 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yeramian Patrick D Chief Medical Officer | 2022-01-06 | Grant or award | +28,333 | 206,333 | D | ||
| Derivatives | |||||||
| Yeramian Patrick D Chief Medical Officer | 2022-01-06 | Grant or award · Stock Option (right to buy) | +127,500 | 127,500 | D | ||
Loading xslF345X03/doc4.xml…